华东医药：公司一直注重对股东的回报

Group 1 - The company emphasizes its commitment to shareholder returns through an active cash dividend policy since its listing [1] - The company plans to propose a dividend plan while considering strategic development needs, R&D investments, and external investment demands [1] - The company aims to balance the needs and actual interests of shareholders with its financial requirements [1]